Biotech firm BlackLabBio has been spun out from the University College Dublin to commercialise engineered protein products. The Ireland-based firm, which has launched with €500,000 ($690k) in support from the Science Foundation Ireland and government agency Enterprise Ireland, is targeting large biotech companies with its products, and is already working with Novartis and AstraZeneca. It…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
